Elevance Health Q3 Earnings Beat Estimates on Strong MA Membership

Key Takeaways ELV posted Q3 EPS of $6.03, beating estimates by 21.1% despite a 29.9% year-over-year decline.Revenues rose 12% to $50.1B, driven by strong premiums, product sales and net investment income.Carelon revenues surged 33% on buyouts and scaling services, while MA growth offset Medicaid declines.Elevance Health, Inc. (ELV) reported third-quarter 2025 adjusted earnings per share (EPS) of $6.03, which surpassed the Zacks Consensus Estimate by 21.1%. The bottom line dropped 29.9% year over year.Operat ...